Status:
NOT_YET_RECRUITING
BCD to Measure the ED95 of Remimazolam-Assisted Sedation in Arteriovenous Fistula Creation Surgery
Lead Sponsor:
Gang Chen
Conditions:
Uremia
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
This study intends to measure the ED95 of remimazolam-assisted sedation in arteriovenous fistula creation by BCD.
Detailed Description
Operative venous fistula (AVF) under local anaesthesia is a common surgical procedure for long-term haemodialysis patients. A common surgical procedure for patients with renal failure on dialysis. How...
Eligibility Criteria
Inclusion
- 18-65 years old (including borderline values).
- Elective surgical patients under local anaesthesia for operation of AVF
- Voluntary participation in this study and signing of informed consent.
- American Society of Anesthesiologists (ASA) classification \< Grade IV.
- BMI range: 18-28kg/m2 (including borderline values).
Exclusion
- hypersensitivity to remimazolam or benzodiazepines.
- patients with severe cardiac, pulmonary, neurological diseases or liver failure. -- Preoperative use of sedative drugs, anticonvulsants, etc.
- patients who cannot cooperate with postoperative recovery or follow-up.
- vulnerable groups, including those with mental illness, cognitive impairment, critically ill patients, pregnant women, illiterates, etc.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06998732
Start Date
June 1 2025
End Date
October 31 2025
Last Update
May 31 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.